Ovarian Cancer in the Elderly: Time to Move towards a More Logical Approach to Improve Prognosis-A Study from the FRANCOGYN Group.
Ludivine DionCamille MimounKrystel Nyangoh TimohSofiane BendifallahAlexandre BricouPierre CollinetCyril TouboulLobna OuldamerHenri AzaïsYohann DabiCherif AkladiosGeoffroy CanlorbePierre-Adrien BolzeHélène CostazMathieu MezzadriTristan GauthierFrederik KridelkaPauline ChauvetNicolas BourdelMartin KoskasXavier CarcopinoEmilie RaimondOlivier GraesslinLise LecointreMarcos BallesterJean LevêqueCyrille HuchonVincent LavouePublished in: Journal of clinical medicine (2020)
Surgeons modify their approach to treating ovarian cancer in women ≥75 years probably to reduce immediate postoperative complications. The prognosis is significantly worse in patients with greater frailty. Improvements to the sequence of treatments administered, with priority given to neoadjuvant chemotherapy in patients with greater frailty, could help increase the number of women who receive optimal treatment and improve their prognosis.
Keyphrases
- neoadjuvant chemotherapy
- polycystic ovary syndrome
- community dwelling
- locally advanced
- lymph node
- sentinel lymph node
- pregnancy outcomes
- cervical cancer screening
- squamous cell carcinoma
- quality improvement
- pregnant women
- radiation therapy
- adipose tissue
- insulin resistance
- skeletal muscle
- rectal cancer
- thoracic surgery